| Title : The dipeptidyl peptidase 4 inhibitor linagliptin ameliorates renal injury and accelerated resolution in a rat model of crescentic nephritis - Mayer_2021_Br.J.Pharmacol_178_878 |
| Author(s) : Mayer AL , Scheitacker I , Ebert N , Klein T , Amann K , Daniel C |
| Ref : British Journal of Pharmacology , 178 :878 , 2021 |
| Abstract : Mayer_2021_Br.J.Pharmacol_178_878 |
| ESTHER : Mayer_2021_Br.J.Pharmacol_178_878 |
| PubMedSearch : Mayer_2021_Br.J.Pharmacol_178_878 |
| PubMedID: 33171531 |
Mayer AL, Scheitacker I, Ebert N, Klein T, Amann K, Daniel C (2021)
The dipeptidyl peptidase 4 inhibitor linagliptin ameliorates renal injury and accelerated resolution in a rat model of crescentic nephritis
British Journal of Pharmacology
178 :878
Mayer AL, Scheitacker I, Ebert N, Klein T, Amann K, Daniel C (2021)
British Journal of Pharmacology
178 :878